Syracuse, United States
Bioneex, established in 2020, is headquartered in the United States. This startup operates in the Biopharma and Biotechnology industries and is making waves with its AI-powered platform. The platform is dual-purpose: it connects drug development companies with strategic biopharma partners and venture capital investors, and it also facilitates the search, evaluation, and due diligence of therapeutic assets.
One of Bioneex's key advantages is its exclusive access to the derisked assets via Derisq™, an AI tool from GATC Health, which simulates human biology. This significantly boosts confidence in asset reliability for clients, which include notable names like Johnson & Johnson, Bayer, AbbVie, and BioNTech.
The company has recently garnered attention with a $500.00K Seed Round investment dated 15 February 2024. Bioneex is dedicated to enhancing the exposure of preclinical and clinical-stage drug companies to the right partners and investors at the right time, aiming to accelerate the journey of novel drug candidates from development to patient care.
